The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Electrophilic natural products and their biological targets
Abstract
The study of biologically active natural products has resulted in seminal contributions to our understanding of living systems. In the case of electrophilic natural products, the covalent nature of their interaction has largely facilitated the identification of their biological binding partners. In this review, we provide a comprehensive compilation of electrophilic natural products from all major chemical classes together with their biological targets. Covering Michael acceptor systems, ring-strained compounds and other electrophiles, such as esters or carbamates, we highlight representative and instructive examples for over 20 electrophilic moieties. The fruitful cooperation of natural product chemistry, medicinal chemistry and chemical biology has produced a collection of well-studied examples for how electrophilic natural products exert their biological functions that range from antibiotic to antitumor effects. Special emphasis is put on the elucidation of their respective biological targets via activity-based protein profiling, which together with the recent advancements in mass spectrometry has been crucial to the success of the field. The wealth of naturally occurring electrophilic moieties and their chemical complexity enables binding of a large variety of biological targets, such as enzymes of all classes, nonenzymatic proteins, DNA and other cellular compounds. With approximately 30,000 genes in the human genome but only 266 confirmed protein drug targets, the study of biologically active, electrophilic natural products has the potential to provide insights into fundamental biological processes and to greatly aid the discovery of new drug targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals
Fornerod, M., Ohno, M., Yoshida, M., & Mattaj, I. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80371-2 · Cited by 2,081
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
Honigberg, L. A., Smith, A. M., Sirisawad, M., Verner, E., Loury, D., Chang, B., Li, S., Pan, Z., Thamm, D. H., Miller, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004594107 · Cited by 1,561
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Activity-Based Protein Profiling: From Enzyme Chemistry to Proteomic Chemistry
Cravatt, B. F., Wright, A. T., & Kozarich, J. W. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.124125 · Cited by 1,270
Activity-based protein profiling: The serine hydrolases
Liu, Y., Patricelli, M. P., & Cravatt, B. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14694 · Cited by 1,133
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines
Macpherson, L. J., Dubin, A. E., Evans, M. J., Marr, F., Schultz, P. G., Cravatt, B. F., & Patapoutian, A. (2007) · Nature · doi:10.1038/nature05544 · Cited by 1,116
Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M., & Horinouchi, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9112 · Cited by 1,029
Barrett, A. J., Kembhavi, A. A., Brown, M. A., Kirschke, H., Knight, C. G., Tamai, M., & Hanada, K. (1982) · Biochemical Journal · doi:10.1042/bj2010189 · Cited by 1,026
Speers, A. E., Adam, G. C., & Cravatt, B. F. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034490h · Cited by 955
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 920
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 913
Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1
Goldberg, J., Huang, H.-B., Kwon, Y.-G., Greengard, P., Nairn, A. C., & Kuriyan, J. (1995) · Nature · doi:10.1038/376745a0 · Cited by 860
Leptomycin B Inhibition of Signal-Mediated Nuclear Export by Direct Binding to CRM1
Kudo, N., Wolff, B., Sekimoto, T., Schreiner, E. P., Yoneda, Y., Yanagida, M., Horinouchi, S., & Yoshida, M. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4136 · Cited by 812
THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)
Kahan, F. M., Kahan, J. S., Cassidy, P. J., & Kropp, H. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb43277.x · Cited by 777
Mechanisms of Aflatoxin Carcinogenesis
Eaton, D. L., & Gallagher, E. P. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001031 · Cited by 774
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 749
Identification of the gene for vitamin K epoxide reductase
Li, T., Chang, C.-Y., Jin, D.-Y., Lin, P.-J., Khvorova, A., & Stafford, D. W. (2004) · Nature · doi:10.1038/nature02254 · Cited by 707
Kwo, P. Y., Lawitz, E. J., McCone, J., Schiff, E. R., Vierling, J. M., Pound, D., Davis, M. N., Galati, J. S., Gordon, S. C., Ravendhran, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60934-8 · Cited by 704
Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M. J., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., & Panayotou, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1722 · Cited by 682
Sin, N., Meng, L., Wang, M. Q. W., Wen, J. J., Bornmann, W. G., & Crews, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6099 · Cited by 635
New antibiotics from bacterial natural products
Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 607
Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces
Hendlin, D., Stapley, E. O., Jackson, M., Wallick, H., Miller, A. K., Wolf, F. J., Miller, T. W., Chaiet, L., Kahan, F. M., Foltz, E. L., et al. (1969) · Science · doi:10.1126/science.166.3901.122 · Cited by 593
Chemistry-Based Functional Proteomics Reveals Novel Members of the Deubiquitinating Enzyme Family
Borodovsky, A., Ovaa, H., Kolli, N., Gan-Erdene, T., Wilkinson, K. D., Ploegh, H. L., & Kessler, B. M. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00248-x · Cited by 588
Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools
Greenbaum, D., Medzihradszky, K. F., Burlingame, A., & Bogyo, M. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00014-4 · Cited by 581
Orlistat, a New Lipase Inhibitor for the Management of Obesity
Heck, A. M., Yanovski, J. A., & Calis, K. A. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.4.270.34882 · Cited by 572
Burstein, H. J., Sun, Y., Dirix, L. Y., Jiang, Z., Paridaens, R., Tan, A. R., Awada, A., Ranade, A., Jiao, S., Schwartz, G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8707 · Cited by 522
Kwok, B. H. B., Koh, B., Ndubuisi, M. I., Elofsson, M., & Crews, C. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00049-7 · Cited by 515
XPB, a subunit of TFIIH, is a target of the natural product triptolide
Titov, D. V., Gilman, B., He, Q.-L., Bhat, S., Low, W.-K., Dang, Y., Smeaton, M., Demain, A. L., Miller, P. S., Kugel, J. F., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.522 · Cited by 509
Vinyl Sulfones as Mechanism-Based Cysteine Protease Inhibitors
Palmer, J. T., Rasnick, D., Klaus, J. L., & Bromme, D. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00017a002 · Cited by 508
Crystallographic analysis of the catalytic mechanism of haloalkane dehalogenase
Verschueren, K. H. G., Seljée, F., Rozeboom, H. J., Kalk, K. H., & Dijkstra, B. W. (1993) · Nature · doi:10.1038/363693a0 · Cited by 467
Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin
Liu, S., Widom, J., Kemp, C. W., Crews, C. M., & Clardy, J. (1998) · Science · doi:10.1126/science.282.5392.1324 · Cited by 440
Bioactive polyacetylenes in food plants of the Apiaceae family: Occurrence, bioactivity and analysis
Christensen, L. P., & Brandt, K. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.01.057 · Cited by 415
Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors
Johnson, D. S., Weerapana, E., & Cravatt, B. F. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.21 · Cited by 387
Xia, Y.-F., Ye, B.-Q., Li, Y.-D., Wang, J.-G., He, X.-J., Lin, X., Yao, X., Ma, D., Slungaard, A., Hebbel, R. P., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4207 · Cited by 378
Smith, A. L., & Nicolaou, K. C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9600398 · Cited by 377
Isolation and Characterization of E–64, a New Thiol Protease Inhibitor
Hanada, K., Tamai, M., Yamagishi, M., Ohmura, S., Sawada, J., & Tanaka, I. (1978) · Agricultural and Biological Chemistry · doi:10.1080/00021369.1978.10863014 · Cited by 365
Bargagna-Mohan, P., Hamza, A., Kim, Y.-E., Khuan (Abby) Ho, Y., Mor-Vaknin, N., Wendschlag, N., Liu, J., Evans, R. M., Markovitz, D. M., Zhan, C.-G., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.04.010 · Cited by 348
Covalent Modifiers: An Orthogonal Approach to Drug Design
Potashman, M. H., & Duggan, M. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8008597 · Cited by 346
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
Hadváry, P., Lengsfeld, H., & Wolfer, H. (1988) · Biochemical Journal · doi:10.1042/bj2560357 · Cited by 345
WEIBEL, E. K., HADVARY, P., HOCHULI, E., KUPFER, E., & LENGSFELD, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1081 · Cited by 341
Curcumin is a potent DNA hypomethylation agent
Liu, Z., Xie, Z., Jones, W., Pavlovicz, R. E., Liu, S., Yu, J., Li, P.-K., Lin, J., Fuchs, J. R., Marcucci, G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.041 · Cited by 330
Groll, M., Huber, R., & Potts, B. C. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja058320b · Cited by 312
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism
Groll, M., Schellenberg, B., Bachmann, A. S., Archer, C. R., Huber, R., Powell, T. K., Lindow, S., Kaiser, M., & Dudler, R. (2008) · Nature · doi:10.1038/nature06782 · Cited by 308
O'Connor, O. A., Stewart, A. K., Vallone, M., Molineaux, C. J., Kunkel, L. A., Gerecitano, J. F., & Orlowski, R. Z. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0822 · Cited by 295
A Role for the Protease Falcipain 1 in Host Cell Invasion by the Human Malaria Parasite
Greenbaum, D. C., Baruch, A., Grainger, M., Bozdech, Z., Medzihradszky, K. F., Engel, J., DeRisi, J., Holder, A. A., & Bogyo, M. (2002) · Science · doi:10.1126/science.1077426 · Cited by 288
Activity-based protein profiling for the functional annotation of enzymes
Barglow, K. T., & Cravatt, B. F. (2007) · Nature Methods · doi:10.1038/nmeth1092 · Cited by 281
Hadváry, P., Sidler, W., Meister, W., Vetter, W., & Wolfer, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52203-1 · Cited by 280
Wissner, A., Overbeek, E., Reich, M. F., Floyd, M. B., Johnson, B. D., Mamuya, N., Rosfjord, E. C., Discafani, C., Davis, R., Shi, X., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020241c · Cited by 264
Skarzynski, T., Mistry, A., Wonacott, A., Hutchinson, S. E., Kelly, V. A., & Duncan, K. (1996) · Structure · doi:10.1016/s0969-2126(96)00153-0 · Cited by 262
Griffith, E. C., Su, Z., Niwayama, S., Ramsay, C. A., Chang, Y.-H., & Liu, J. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15183 · Cited by 262
Chemical Strategies for Activity‐Based Proteomics
Speers, A. E., & Cravatt, B. F. (2004) · ChemBioChem · doi:10.1002/cbic.200300721 · Cited by 258
Protein‐Reactive Natural Products
Drahl, C., Cravatt, B. F., & Sorensen, E. J. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500900 · Cited by 250
Block, E., Ahmad, S., Jain, M. K., Crecely, R. W., Apitz-Castro, R., & Cruz, M. R. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00338a049 · Cited by 246
Yang, P.-Y., Liu, K., Ngai, M. H., Lear, M. J., Wenk, M. R., & Yao, S. Q. (2010) · Journal of the American Chemical Society · doi:10.1021/ja907716f · Cited by 229
Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin in Cultured Cells
Dick, L. R., Cruikshank, A. A., Destree, A. T., Grenier, L., McCormack, T. A., Melandri, F. D., Nunes, S. L., Palombella, V. J., Parent, L. A., Plamondon, L., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.182 · Cited by 228
Boger, D. L., & Johnson, D. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3642 · Cited by 217
Cabello, C. M., Bair, W. B., Lamore, S. D., Ley, S., Bause, A. S., Azimian, S., & Wondrak, G. T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.025 · Cited by 214
Epoxomicin, a new antitumor agent of microbial origin.
HANADA, M., SUGAWARA, K., KANETA, K., TODA, S., NISHIYAMA, Y., TOMITA, K., YAMAMOTO, H., KONISHI, M., & OKI, T. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1746 · Cited by 213
Natural Products and Their Biological Targets: Proteomic and Metabolomic Labeling Strategies
Böttcher, T., Pitscheider, M., & Sieber, S. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200905352 · Cited by 212
Self-citationBrown, E. D., Vivas, E. I., Walsh, C. T., & Kolter, R. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4194-4197.1995 · Cited by 212
Phosphoinositide 3-kinase in disease: timing, location, and scaffolding
Wymann, M. P., & Marone, R. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.011 · Cited by 209
Liu, Y., Shreder, K. R., Gai, W., Corral, S., Ferris, D. K., & Rosenblum, J. S. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.009 · Cited by 209
Böttcher, T., & Sieber, S. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8051365 · Cited by 207
Self-citationHurley, L. H., Reynolds, V. L., Swenson, D. H., Petzold, G. L., & Scahill, T. A. (1984) · Science · doi:10.1126/science.6494915 · Cited by 203
Covalent Binding to Tubulin by Isothiocyanates
Mi, L., Xiao, Z., Hood, B. L., Dakshanamurthy, S., Wang, X., Govind, S., Conrads, T. P., Veenstra, T. D., & Chung, F.-L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802330200 · Cited by 199
Fosfomycin: an old, new friend?
Popovic, M., Steinort, D., Pillai, S., & Joukhadar, C. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0833-2 · Cited by 197
Takada, Y., Murakami, A., & Aggarwal, B. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208845 · Cited by 196
Gastinel, L. N. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.638 · Cited by 192
Taunton, J., Collins, J. L., & Schreiber, S. L. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9615841 · Cited by 192
Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors
Rosenthal, P. J., Olson, J. E., Lee, G. K., Palmer, J. T., Klaus, J. L., & Rasnick, D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1600 · Cited by 189
Böttcher, T., & Sieber, S. A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705768 · Cited by 181
Self-citationXu, W., Ngo, L., Perez, G., Dokmanovic, M., & Marks, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607518103 · Cited by 179
Targeted covalent drugs of the kinase family
Singh, J., Petter, R. C., & Kluge, A. F. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.168 · Cited by 177
HAMAMOTO, T., GUNJI, S., TSUJI, H., & BEPPU, T. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.639 · Cited by 168
A Cell-permeable, Activity-based Probe for Protein and Lipid Kinases
Yee, M.-C., Fas, S. C., Stohlmeyer, M. M., Wandless, T. J., & Cimprich, K. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504730200 · Cited by 166
Jaspers, N. G. J., Raams, A., Kelner, M. J., Ng, J. M. Y., Yamashita, Y. M., Takeda, S., McMorris, T. C., & Hoeijmakers, J. H. J. (2002) · DNA Repair · doi:10.1016/s1568-7864(02)00166-0 · Cited by 165
A Mild Chemically Cleavable Linker System for Functional Proteomic Applications
Verhelst, S. H. L., Fonović, M., & Bogyo, M. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603811 · Cited by 163
Activity Profiling of Papain-Like Cysteine Proteases in Plants
van der Hoorn, R. A. L., Leeuwenburgh, M. A., Bogyo, M. S., et al. (2004) · PLANT PHYSIOLOGY · doi:10.1104/pp.104.041467 · Cited by 157
Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites
Buey, R. M., Calvo, E., Barasoain, I., Pineda, O., Edler, M. C., Matesanz, R., Cerezo, G., Vanderwal, C. D., Day, B. W., Sorensen, E. J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio853 · Cited by 156
Chew, E., Nagle, A. A., Zhang, Y., Scarmagnani, S., Palaniappan, P. L. R. M., Bradshaw, T. D., Holmgren, A., & Westwell, A. D. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.028 · Cited by 156
Eponemycin exerts its antitumor effect through the inhibition of proteasome function.
Meng, L., Kwok, B. H. B., Sin, N., & Crews, C. M. (1999) · PubMed · Cited by 155
Marquardt, J. L., Brown, E. D., Lane, W. S., Haley, T. M., Ichikawa, Y., Wong, C., & Walsh, C. T. (1994) · Biochemistry · doi:10.1021/bi00201a011 · Cited by 145
Electrophiles in Foods: The Current Status of Isothiocyanates and Their Chemical Biology
NAKAMURA, Y., & MIYOSHI, N. (2010) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.90731 · Cited by 143
Biological targets of isothiocyanates
Brown, K., & Hampton, M. B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.004 · Cited by 143
Valilactone, an inhibitor of esterase, produced by actinomycetes.
Kitahara, M., Asano, M., NAGANAWA, H., Maeda, K., HAMADA, M., AOYAGI, T., UMEZAWA, H., IITAKA, Y., & Nakamura, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1647 · Cited by 142
Eschenburg, S., Priestman, M. A., & Schönbrunn, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411325200 · Cited by 141
15-Deoxy-Δ12,14-prostaglandin J2: An Electrophilic Trigger of Cellular Responses
Uchida, K., & Shibata, T. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700177j · Cited by 140
Mi, L., Wang, X., Govind, S., Hood, B. L., Veenstra, T. D., Conrads, T. P., Saha, D. T., Goldman, R., & Chung, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0340 · Cited by 139
Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers
Stopfer, P., Marzin, K., Narjes, H., Gansser, D., Shahidi, M., Uttereuther-Fischer, M., & Ebner, T. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1803-9 · Cited by 137
A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor
Koteva, K. K., Hong, H., Wang, X. D., Nazi, I., Hughes, D. W., Naldrett, M. J., Buttner, M. J., & Wright, G. D. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.350 · Cited by 137
A Mild Chemically Cleavable Linker System for Functional Proteomic Applications
Verhelst, S. H. L., Fonovič, M., & Bogyo, M. S. (2007) · Angewandte Chemie · doi:10.1002/ange.200603811 · Cited by 133
AN ANTIPHAGE AGENT ISOLATED FROM ASPERGILLUS SP
Hanson, F. R., & Eble, T. E. (1949) · Journal of Bacteriology · doi:10.1128/jb.58.4.527-529.1949 · Cited by 129
Gallwitz, H., Bonse, S., Martinez-Cruz, A., Schlichting, I., Schumacher, K., & Krauth-Siegel, R. L. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980471k · Cited by 127
Murakami, A., Takahashi, M., Jiwajinda, S., Koshimįzu, K., & Ohigashi, H. (1999) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.63.1811 · Cited by 127
Lowther, W. T., McMillen, D. A., Orville, A. M., & Matthews, B. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12153 · Cited by 127
Leptomycins A and B, new antifungal antibiotics. II. Structure elucidation.
Hamamoto, T., Seto, H., & Beppu, T. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.646 · Cited by 127
Wäspi, U., Blanc, D., Winkler, T., Rüedi, P., & Dudler, R. (1998) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi.1998.11.8.727 · Cited by 123
Koeberle, A., Northoff, H., & Werz, O. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0290 · Cited by 122
Biochemical Target Isolation for Novices: Affinity-Based Strategies
Sato, S., Murata, A., Shirakawa, T., & Uesugi, M. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.015 · Cited by 120
Staub, I., & Sieber, S. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803349j · Cited by 120
Self-citationNovel interstrand cross-links induced by the antitumor antibiotic carzinophilin/azinomycin B
Armstrong, R. W., Salvati, M., & Nguyen, M. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a074 · Cited by 120
Trypanosoma brucei CTP synthetase: A target for the treatment of African sleeping sickness
Hofer, A., Steverding, D., Chabes, A., Brun, R., & Thelander, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111139498 · Cited by 118
Kim, K. B., Myung, J., Sin, N., & Crews, C. M. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00612-5 · Cited by 116
Chemistry of the Cysteine Sensors in Kelch-Like ECH-Associated Protein 1
Holland, R., & Fishbein, J. C. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3273 · Cited by 115
Maiese, W. M., Lechevalier, M. P., Lechevalier, H. A., KORSHALLA, J. D., KUCK, N. A., Fantini, A. A., Wildey, M. J., Thomas, J., & Greenstein, M. D. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.558 · Cited by 110
Singh, J., Dobrusin, E. M., Fry, D. W., Haske, T., Whitty, A., & McNamara, D. J. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960380s · Cited by 108
The Anticancer Natural Product Pironetin Selectively Targets Lys352 of α-Tubulin
Usui, T., Watanabe, H., Nakayama, H., Tada, Y., Kanoh, N., Kondoh, M., Asao, T., Takio, K., Watanabe, H., Nishikawa, K., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.028 · Cited by 106
A New Antibiotic CJ-17,665 from Aspergillus ochraceus.
Sugie, Y., Hirai, H., INAGAKI, T., ISHIGURO, M., Kim, Y.-J., Kojima, Y., SAKAKIBARA, T., Sakemi, S., Sugiura, A., Suzuki, Y., et al. (2001) · The Journal of Antibiotics · doi:10.7164/antibiotics.54.911 · Cited by 104
Azinomycins A and B, new antitumor antibiotics. II Chemical structures.
YOKOI, K., NAGAOKA, K., & NAKASHIMA, T. (1986) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.34.4554 · Cited by 101
Unraveling the Protein Targets of Vancomycin in Living S. aureus and E. faecalis Cells
Eirich, J., Orth, R., & Sieber, S. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2039979 · Cited by 99
Self-citation“Back Door” Opening Implied by the Crystal Structure of a Carbamoylated Acetylcholinesterase
Bartolucci, C., Perola, E., Cellai, L., et al. (1999) · Biochemistry · doi:10.1021/bi982723p · Cited by 97
Prodrugs for Targeted Tumor Therapies: Recent Developments in ADEPT, GDEPT and PMT
Tietze, L. F., & Schmuck, K. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798194459 · Cited by 96
Leonti, M., Casu, L., Raduner, S., Cottiglia, F., Floris, C., Altmann, K.-H., & Gertsch, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.015 · Cited by 95
Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine
Hagel, M., Niu, D., St Martin, T., Sheets, M. P., Qiao, L., Bernard, H., Karp, R. M., Zhu, Z., Labenski, M. T., Chaturvedi, P., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.492 · Cited by 95
Böttcher, T., & Sieber, S. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909150y · Cited by 89
Self-citationDick, F. A., Karamanou, S., & Trumpower, B. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13372 · Cited by 87
Ratjadones inhibit nuclear export by blocking CRM1/exportin 1
Köster, M., Lykke‐Andersen, S., Elnakady, Y. A., Gerth, K., Washausen, P., Höfle, G., Sasse, F., Kjems, J., & Häuser, H. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00100-9 · Cited by 85
The Natural Product Avrainvillamide Binds to the Oncoprotein Nucleophosmin
Wulff, J. E., Siegrist, R., & Myers, A. G. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075327f · Cited by 84
Polo-like Kinases Inhibited by Wortmannin
Liu, Y., Jiang, N., Wu, J., Dai, W. H., & Rosenblum, J. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609603200 · Cited by 83
β-Lactams and β-lactones as activity-based probes in chemical biology
Böttcher, T., & Sieber, S. A. (2012) · MedChemComm · doi:10.1039/c2md00275b · Cited by 83
Self-citationZeiler, E., Braun, N., Böttcher, T., Kastenmüller, A., Weinkauf, S., & Sieber, S. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104391 · Cited by 82
Self-citationGarlic‐derived anticancer agents: Structure and biological activity of ajoene
Kaschula, C. H., Hunter, R., & Parker, M. I. (2010) · BioFactors · doi:10.1002/biof.76 · Cited by 82
Chen, H., Lin, A., Chu, H.-C., Li, C., Tsai, C.-W., Chao, C., Wang, C., Lii, C., & Liu, K. (2011) · Journal of Natural Products · doi:10.1021/np200631v · Cited by 81
Wang, Y.-J., Wang, J.-T., Fan, Q.-X., & Geng, J.-G. (2007) · Cell Research · doi:10.1038/cr.2007.89 · Cited by 80
Duocarmycin Analogues Target Aldehyde Dehydrogenase 1 in Lung Cancer Cells
Wirth, T., Schmuck, K., Tietze, L. F., & Sieber, S. A. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201106334 · Cited by 80
Self-citationZhang, P., Nicholson, D. E., Bujnicki, J. M., Su, X., Brendle, J. J., Ferdig, M. T., Kyle, D. E., Milhous, W. K., & Chiang, P. K. (2002) · Journal of Biomedical Science · doi:10.1007/bf02256576 · Cited by 79
Application of activity-based probes to the study of enzymes involved in cancer progression
Paulick, M. G., & Bogyo, M. S. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.001 · Cited by 78
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins
Machebœuf, P., Fischer, D. S., Brown, T., Zervosen, A., Luxen, A., Joris, B., Dessen, A., & Schofield, C. J. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.21 · Cited by 72
Farha, M. A., & Brown, E. D. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.06.008 · Cited by 70
Shin, J.-W., Ohnishi, K., Murakami, A., Lee, J., Kundu, J. K., Na, H.-K., Ohigashi, H., & Surh, Y. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0354 · Cited by 70
Development of withaferin A analogs as probes of angiogenesis
Yokota, Y., Bargagna‐Mohan, P., Ravindranath, P. P., Kim, K. B., & Mohan, R. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.02.039 · Cited by 68
Clerc, J., Florea, B. I., Kraus, M., Groll, M., Huber, R., Bachmann, A. S., Dudler, R., Driessen, C., Overkleeft, H. S., & Kaiser, M. (2009) · ChemBioChem · doi:10.1002/cbic.200900411 · Cited by 67
Duocarmycin Analogues Target Aldehyde Dehydrogenase 1 in Lung Cancer Cells
Wirth, T., Schmuck, K., Tietze, L. F., & Sieber, S. A. (2012) · Angewandte Chemie · doi:10.1002/ange.201106334 · Cited by 67
Self-citationTso, J. Y., Bower, S. G., & Zalkin, H. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43633-2 · Cited by 66
Proteasome Activity Imaging and Profiling Characterizes Bacterial Effector Syringolin A
Kołodziejek, I., Villamil, J. C. M., Kaschani, F., Clerc, J., Gu, C., Krahn, D., Niessen, S., Verdoes, M., Willems, L. I., Overkleeft, H. S., et al. (2010) · PLANT PHYSIOLOGY · doi:10.1104/pp.110.163733 · Cited by 66
Cellular targets of natural products
Dixon, N., Wong, L. S., Geerlings, T. H., & Micklefield, J. (2007) · Natural Product Reports · doi:10.1039/b616808f · Cited by 66
Viswesh, V. V., Gates, K. S., & Sun, D. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900301r · Cited by 64
Using Small Molecules To Dissect Mechanisms of Microbial Pathogenesis
Puri, A. W., & Bogyo, M. S. (2009) · ACS Chemical Biology · doi:10.1021/cb9001409 · Cited by 64
(−)‐FR182877 Is a Potent and Selective Inhibitor of Carboxylesterase‐1
Adam, G. C., Vanderwal, C. D., Sorensen, E. J., & Cravatt, B. F. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200352576 · Cited by 63
HARADA, S., Tsubotani, S., HIDA, T., Onο, H., & Okazaki, H. (1986) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)85439-8 · Cited by 62
The chemistry and biology of syringolins, glidobactins and cepafungins (syrbactins)
Krahn, D., Ottmann, C., & Kaiser, M. (2011) · Natural Product Reports · doi:10.1039/c1np00048a · Cited by 60
Chen, X., Xie, S., Bhat, S., Kumar, N., Shapiro, T. A., & Liu, J. O. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.006 · Cited by 59
Click-based synthesis and proteomic profiling of lipstatin analogues
Ngai, M. H., Yang, P., Liu, K., Shen, Y., Wenk, M. R., Yao, S. Q., & Lear, M. J. (2010) · Chemical Communications · doi:10.1039/c0cc01276a · Cited by 57
Lee, A. Y., Hagihara, M., Karmacharya, R., Albers, M. W., Schreiber, S. L., & Clardy, J. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00079a065 · Cited by 57
Structure and reactivity of illudins
McMorris, T. C., Kelner, M. J., Chadha, R. K., Siegel, J. S., Moon, S., & Moya, M. M. (1989) · Tetrahedron · doi:10.1016/s0040-4020(01)89489-8 · Cited by 52
Different sites of acivicin binding and inactivation of gamma-glutamyl transpeptidases.
Smith, T., Ikeda, Y., Fujii, J., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2360 · Cited by 52
Allergic contact dermatitis from falcarinol isolated from Schefflera arboricola
Hansen, L., Hammershøy, O., & Boll, P. M. (1986) · Contact Dermatitis · doi:10.1111/j.1600-0536.1986.tb01167.x · Cited by 51
Activity-Based Protein Profiling for Natural Product Target Discovery
Krysiak, J. M., & Breinbauer, R. (2011) · Topics in current chemistry · doi:10.1007/128_2011_289 · Cited by 50
In VitroCovalent Binding Proteins of Zerumbone, a Chemopreventive Food Factor
Ohnishi, K., Irie, K., & Murakami, A. (2009) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90265 · Cited by 50
Clerc, J., Li, N., Krahn, D., Groll, M., Bachmann, A. S., Florea, B. I., Overkleeft, H. S., & Kaiser, M. (2010) · Chemical Communications · doi:10.1039/c0cc02238a · Cited by 50
Shreder, K. R., Liu, Y., Nomanhboy, T., Fuller, S. R., Wong, M. S., Gai, W. Z., Wu, J., Leventhal, P. S., Lill, J. R., & Corral, S. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499580 · Cited by 46
Peptidyl Aldehydes as Reversible Covalent Inhibitors of Protein Tyrosine Phosphatases
Fu, H., Park, J., & Pei, D. (2002) · Biochemistry · doi:10.1021/bi0258748 · Cited by 46
ABPP Methodology: Introduction and Overview
Nodwell, M. B., & Sieber, S. A. (2011) · Topics in current chemistry · doi:10.1007/128_2011_302 · Cited by 44
Self-citationSulphones derived from methylthiopropenoic acid amides from Glycosmis angustifolia
Greger, H., Hofer, O., Zechner, G., Hadaček, F., & Wurz, G. (1994) · Phytochemistry · doi:10.1016/s0031-9422(00)90403-5 · Cited by 43
Total synthesis of miraziridine A and identification of its major reaction site for cathepsin B
Konno, H., Kubo, K., Makabe, H., et al. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.06.082 · Cited by 41
Conti, P., Pinto, A., Wong, P. E., Major, L. L., Tamborini, L., Iannuzzi, M. C., Micheli, C. D., Barrett, M. P., & Smith, T. (2010) · ChemMedChem · doi:10.1002/cmdc.201000417 · Cited by 38
Triptolide binds covalently to a 90 kDa nuclear protein. Role of epoxides in binding and activity
McCallum, C. D., Kwon, S., Leavitt, P. S., Shen, D., Liu, W., & Gurnett, A. M. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.02.002 · Cited by 35
Natural products: chemical instruments to apprehend biological symphony
Pucheault, M. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b713022h · Cited by 34
Liu, X., Pietsch, K. E., & Sturla, S. J. (2011) · Chemical Research in Toxicology · doi:10.1021/tx2000152 · Cited by 33
Cellular Effects Induced by the Antitumor Agent Azinomycin B
Kelly, G. T., Liu, C., Smith, R., Coleman, R. S., & Watanabe, C. M. H. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.02.015 · Cited by 31
Tomoda, H., Ohbayashi, N., Morikawa, Y., KUMAGAI, H., & Ōmura, S. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.11.005 · Cited by 30
The biological targets of acivicin inspired 3-chloro- and 3-bromodihydroisoxazole scaffolds
Orth, R., Böttcher, T., & Sieber, S. A. (2010) · Chemical Communications · doi:10.1039/c0cc02825h · Cited by 30
Self-citationProtein Reactivity of Natural Product-Derived γ-Butyrolactones
Kunzmann, M. H., Staub, I., Böttcher, T., & Sieber, S. A. (2010) · Biochemistry · doi:10.1021/bi101858g · Cited by 27
Self-citationLiu, X., & Sturla, S. J. (2009) · Molecular BioSystems · doi:10.1039/b904720d · Cited by 21
Structural Basis for the Interaction of Lactivicins with Serine β-Lactamases
Brown, T., Charlier, P., Herman, R., Schofield, C. J., & Sauvage, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100437u · Cited by 21
Synthesis and antibacterial activity of lactivicin derivatives.
TAMURA, N., MATSUSHITA, Y., KAWANO, Y., & YOSHIOKA, K. (1990) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.38.116 · Cited by 21
In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma
Elliott, W. L., & Weber, G. F. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90131-5 · Cited by 20
Phase II study of acivicin in patients with recurrent high grade astrocytoma
Olver, I., Green, M., Millward, M., & Bishop, J. F. (1998) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(98)90201-6 · Cited by 16
Activity-Based Profiling for Drug Discovery
Serwa, R. A., & Tate, E. W. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.04.002 · Cited by 14
Phase II Trial of Acivicin in Patients with Advanced Colorectal Carcinoma
Adolphson, C. C., Ajani, J. A., Stroehlein, J. R., Barlogie, B., Bodey, G. P., Korinek, J. K., & Bedikian, A. Y. (1986) · American Journal of Clinical Oncology · doi:10.1097/00000421-198606000-00003 · Cited by 13
Cinnamic aldehyde derived probes for the active site labelling of pathogenesis associated enzymes
Pitscheider, M., & Sieber, S. A. (2009) · Chemical Communications · doi:10.1039/b905527d · Cited by 11
Self-citationThiol-Activated DNA Damage by α-Bromo-2-cyclopentenone
Fekry, M. I., Price, N. E., Zang, H., Huang, C., Harmata, M. A., Brown, P., Daniels, J. S., & Gates, K. S. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100282b · Cited by 11
Zhang, X., Luo, L., & Ma, Z. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-4983-6 · Cited by 5
Cited by
Nrf2, the Master Regulator of Anti-Oxidative Responses
Vomund, S., Schäfer, A., Parnham, M., Brüne, B., & Von Knethen, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122772 · Cited by 752
Baell, J. B. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00947 · Cited by 539
Chemical proteomics approaches for identifying the cellular targets of natural products
Wright, M. H., & Sieber, S. A. (2016) · Natural Product Reports · doi:10.1039/c6np00001k · Cited by 391
Self-citationEnzyme Inhibitor Discovery by Activity-Based Protein Profiling
Niphakis, M. J., & Cravatt, B. F. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035708 · Cited by 366
Covalent inhibitors design and discovery.
De Cesco, S., Kurian, J., Dufresne, C., Mittermaier, A. K., & Moitessier, N. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.019 · Cited by 315
Metadata
- Authors
- Gersch, M., Kreuzer, J., & Sieber, S. A.
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2012
- Volume
- 29
- Issue
- 6
- Pages
- 659
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2144706975
- Cited by
- 282
- References
- 179
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.